Adelaide’s OmnigeniQ wants to build world’s first holographic human twin
While building a bioreactor for NASA, co-founders Jordana Blackman and Tiffanwy Klippel-Cooper imagined a new way to think about how biology and physics intertwine.
Drug discovery is a slow and arduous process, and accelerating it has long been a north star for the biotech industry. But a South Australian startup believes that computing biology directly from physics could transform predictive and preventative medicine.
OmnigeniQ, founded by Jordana Blackman and Tiffanwy Klippel-Cooper, is on a mission to build the world’s first holographic twin of the human body — a living, physics-accurate model designed to improve drug development and enable more precise medicine.
“We’ve built a deterministic system that actually computes biology directly from physics so that we can conduct experiments across life sciences completely in silico,” Blackman chief executive of OmnigeniQ, told Capital Brief.
At the JP Morgan Healthcare Conference in San Francisco on Tuesday — the largest healthcare investment symposium in the world — the startup unveiled a world-first look at a fully folded protein computed directly from DNA.
